Is intrauterine exchange transfusion a safe procedure for management of fetal anaemia?

ObjectiveTo study modalities and complications of intrauterine exchange transfusion (IUET) for the management of severe fetal anaemia.Study designRetrospective study of all IUET procedures performed between January 1999 and January 2012 at a regional centre. Characteristics of each procedure were studied to identify risk factors for complications. Survival rates according to the different aetiologies of anaemia were evaluated.ResultsIn total, 225 IUET procedures were performed in 96 fetuses. Major indications were feto-maternal erythrocyte alloimmunization (n = 80/96, 83.3%) and parvovirus B19 infection (n = 13/96, 13.5%). Twenty-six percent of the fetuses (25/96) had hydrops fetalis before the first IUET. Intrauterine fetal death occurred after 2.7% (6/225) of procedures, premature rupture of the membranes occurred after 0.9% (2/225) of procedures, and emergency caesarean section was required after 3.6% (8/225) of procedures. Fetal bradycardia [odds ratio (OR) 37, 95% confidence interval (CI) 8.3-170; p < 0.01] and gestational age up to 32 weeks (OR 3.67; 95% CI, 1.07-12.58; p = 0.038] were significantly associated with complications after IUET. Complications occurred in 17.7% of pregnancies (17/96) and 7.5% of IUET procedures (17/225). The overall survival rate in the study cohort was 87.5% (84/96): 90% (72/80) in the alloimmunization group and 76.9% (10/13) in the parvovirus-infected group (NS).ConclusionIUET has a higher complication rate than simple intrauterine transfusion, and should be performed by well-trained specialists.